首页 | 本学科首页   官方微博 | 高级检索  
检索        

石杉碱甲聚乳酸-乙醇酸纳米粒的制备、表征及其小鼠活体成像脑靶向分布
引用本文:张瑞华,李丽琴,王陈,鹿晓晶,石童,徐建富,宋良才,王惠芳.石杉碱甲聚乳酸-乙醇酸纳米粒的制备、表征及其小鼠活体成像脑靶向分布[J].国际药学研究杂志,2014,41(2):221-226.
作者姓名:张瑞华  李丽琴  王陈  鹿晓晶  石童  徐建富  宋良才  王惠芳
作者单位:张瑞华 (防化研究院,北京,102205); 李丽琴 (防化研究院,北京,102205); 王陈 (防化研究院,北京,102205); 鹿晓晶 (防化研究院,北京,102205); 石童 (防化研究院,北京,102205); 徐建富 (防化研究院,北京,102205); 宋良才 (防化研究院,北京,102205); 王惠芳 (防化研究院,北京,102205);
摘    要:目的 制备石杉碱甲(HupA)聚乳酸-乙醇酸共聚物(PLGA)纳米粒,并研究其分布特性.方法 以PLGA为载体材料,采用乳化溶剂挥发法,正交实验优化HupA-PLGA纳米粒的制备工艺;透射电子显微镜观察纳米粒形态;激光粒度仪测定平均粒径、粒径分布和Zeta电位;HPLC法测定纳米粒的包封率;并通过小动物活体荧光成像实验对纳米粒在小鼠体内的分布特性进行研究.结果 优化条件下制备的纳米粒呈圆形,大小较为均一,平均粒径为(46.49±1.37)nm,多分散指数值为0.31±0.01,Zeta电位为(-38.3±1.56)mV,包封率为(28.45±1.52)%,且工艺重现性好.小动物活体成像实验结果表明该纳米粒可以通过血脑屏障到达脑组织,且具有很好的缓释作用.结论 以PLGA为载体的HupA纳米粒具有较小的粒径、良好的缓释性能并能提高脑内药物浓度水平.

关 键 词:石杉碱甲  聚乳酸-乙醇酸  正交实验  纳米粒  活体成像

Preparation,characterization and brain targeting efficiency in mice of huperzine A-PLGA nanoparticle
ZHANG Rui-hua,LI Li-qin,WANG Chen,LU Xiao-jing,SHI Tong,XU Jian-fu,SONG Liang-cai,WANG Hui-fang.Preparation,characterization and brain targeting efficiency in mice of huperzine A-PLGA nanoparticle[J].Foreign Medical Sciences(Section of Pharmarcy),2014,41(2):221-226.
Authors:ZHANG Rui-hua  LI Li-qin  WANG Chen  LU Xiao-jing  SHI Tong  XU Jian-fu  SONG Liang-cai  WANG Hui-fang
Institution:(Research Institute of Chemical Defense,Beijing 102205, China)
Abstract:Objective To prepare huperzine A ( HupA ) -poly ( lactic-co-glycolic acid ) (PLGA) nanoparticles ( HupA-PLGA- NP) and to study their distribution property in mice. Methods HupA-PLGA-NP were prepared by emulsion solvent evaporation meth- od with PLGA as the carrier material, and the formulations were optimized by orthogonal design test. Nanoparticles were characterized by transmission electron microscopy ( TEM ) and laser particle diameter analyzer. Encapsulation efficiency ( EE ) was detected by HPLC. Distribution of nanoparticles in mice was evaluated by in vivo imaging system. Results The nanoparticles prepared by the opti- mal preparation were uniform spherical particles by TEM. Mean diameter, polydisperse index and Zeta potential of nanoparticles were (46. 49 ± 1.37) nm, (0. 31 ± 0. 01 ) and ( - 38. 3 ± 1.56) mV, respectively. EE was (28.45 ± 1.52) %. The verifying experiments indicated that the repeatibility of the experiment was satisfactory. Results of in vivo imaging confirmed that nanoparticles with the diam- eter of about 50 nm could cross blood-brain barrier into brain and had good sustained-release effect. Conclusion HupA-PLGA-NP are found to have smaller particle size, sustained release of HupA and elevated drug concentration in brain.
Keywords:huperzine A  poly( lactic-co-glycolic acid)  orthogonal design test  nanoparticles  in vivo imaging
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号